Endogenous estrogens as carcinogens through metabolic activation.
about
Estrogen, progesterone and epithelial ovarian cancerMalignant transformation of rat kidney induced by environmental substances and estrogenQuantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostateEffects of estrogen on breast cancer development: Role of estrogen receptor independent mechanismsCyclooxygenase-2 and the inflammogenesis of breast cancer.The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.Association of variants in estrogen-related pathway genes with prostate cancer risk.Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer riskPolymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast diseaseSex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat.Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genesGenetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women's Health StudyPolymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologistsAntioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines.Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsivenessUnexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugationMorphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptorsThe 4-hydroxyestrone: Electron emission, formation of secondary metabolites and mechanisms of carcinogenesisAssociation between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism.Body burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant womenAssociations between Dietary Intake of Fruits and Vegetables in relation to Urinary Estrogen DNA Adduct RatioAssociations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women.Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesisAntioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancerRelation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women.How to reduce your cancer risk: mechanisms and myths.Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants.Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studiesMechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A reviewAssociations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt.Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women.Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Investigation of prognostic value of polymorphisms within estrogen metabolizing genes in Lithuanian breast cancer patientsPostmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer
P2860
Q24805637-FE37CD12-C707-4C3C-BEDA-D7CB72FF7790Q28385903-6A02D6BA-28D2-4E78-B2BA-3FEFE538A1E9Q28755344-C9FAEDD9-B68B-44D3-B347-A2B139148976Q30360376-D83D4CFA-42E9-487A-9036-5F39D7617392Q30367680-EB1B21C1-6852-4916-ADC0-40CEB41F48CDQ30432909-F218769A-ED47-4A66-A0A3-290C88293BCFQ30532192-86B2AC67-A302-47AD-8BD6-4DACBD75002FQ31138546-86A0C615-A938-41EA-9E9A-9714E5A2A117Q33248389-B37CCD27-0FDB-4700-8B2A-BDA549DCBA96Q33295021-D2D89A3B-E92C-4E8D-9AF9-039874FB4C96Q33422906-93F4B481-A089-4FFE-8AA6-DD5D94BA447AQ33490603-8FD18962-FF5B-4AB2-9250-B1A2075D58BAQ33718754-741181B7-C5E8-4162-BD1A-7B1215C79FB4Q33813463-63565C5A-3955-45BB-998E-BC8F0189CEB7Q33889022-8129F10F-66C3-4F72-A199-61C45FF09512Q33901405-74D66A65-BF85-473E-8F85-2ED9A9681EC4Q34038020-0B50F3DF-D823-4AE0-95B9-FDB6E7DC5291Q34138965-3A16A228-8F61-4D60-B590-48EC5D3D1045Q34148850-A5723936-FD41-4A85-B1C1-5EB549291A37Q34200783-BDE3A622-30F2-47A0-9E32-4C7C7E4C6148Q34333680-26F80312-D63F-4C03-93F2-E136A4967BDAQ34383204-276F3993-AE7D-4D17-95B3-8A4655CD2C28Q34480612-6AB90EFC-E50C-4C6D-A80C-595B29B58A06Q34508116-F59913DB-188E-446C-BC21-B985BEC4D496Q34521954-479A2DA9-97B3-4DB0-9B9A-E7FD13ED5208Q34562296-78554865-4AD2-4E02-A595-0A2B1BC1A453Q34628455-ADB7A3DD-87F2-47A9-8BE6-493648ABA132Q34641803-78010180-1A94-49F1-9AD0-A7630AA08B13Q34734464-52670114-84FF-4710-B932-6FBB7865DCBCQ34768092-1EBF9F06-80FB-4B0C-BEC1-61554CBB61C3Q34894797-76686099-0D3F-4F4C-823F-600A92B365CCQ34983069-E69174DB-31F4-4286-B119-F607CBA144F1Q35092205-D28E0B63-DE6D-46B3-963E-DC1D68684B9DQ35118917-FFE07571-CDBD-4A7F-906A-45B90626D2D7Q35136621-8FB88F85-FD16-4805-B0E4-DA6838156BD5Q35139194-5E29646C-9893-4285-955B-4D52A0AD578EQ35154503-EDB7A83E-53F5-4AC3-B548-3A5C95CE84ECQ35196710-39241F6F-8E7C-4F8A-871A-821C92AF22FDQ35541193-1B28AC64-FAE3-498F-97F5-095A638ADC42Q35620661-B36341A1-CEA1-4B7A-A291-567AD41AA26C
P2860
Endogenous estrogens as carcinogens through metabolic activation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Endogenous estrogens as carcinogens through metabolic activation.
@ast
Endogenous estrogens as carcinogens through metabolic activation.
@en
Endogenous estrogens as carcinogens through metabolic activation.
@nl
type
label
Endogenous estrogens as carcinogens through metabolic activation.
@ast
Endogenous estrogens as carcinogens through metabolic activation.
@en
Endogenous estrogens as carcinogens through metabolic activation.
@nl
prefLabel
Endogenous estrogens as carcinogens through metabolic activation.
@ast
Endogenous estrogens as carcinogens through metabolic activation.
@en
Endogenous estrogens as carcinogens through metabolic activation.
@nl
P1476
Endogenous estrogens as carcinogens through metabolic activation
@en
P2093
P356
10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A024245
P577
2000-01-01T00:00:00Z